Introduction
Transition from Clinical Trials to Real-World Evidence in Plaque Psoriasis and Psoriatic Arthritis
Objectives
•Present current scientific evidence, including clinical trials, Real-world data, and illustrative case studies, on the management of PsO and PsA.
•Communicate Ixekizumab value proposition to highlight what the product may mean to people living with Plaque Psoriasis (PsO) and Psoriatic Arthritis (PsA).
This Course For :
Physician
( Dermatology , Rheumatology )
Resident / Fellow
( Dermatology , Rheumatology )
Clinical Pharmacy
Pharmacy
Speaker
Nada Al Ghamdi
Assistant Professor - Dermatology - Imam Abdulrahman Bin Faisal University
Consultant Dermatologist - King Fahad University Hospital
Al Khobr, Saudi Arabia
Dr OSAMA Haji
Senior Consultant Rheumatologist & Deputy of Internal Medicine training Program
Internal Medicine Department
Al Mouwasat Hospital, Dammam
Dr. ABDULLATIF MOHAMMAD AL- ARFAJ
Consultant, Rheumatology Department of Internal Medicine
Chairman Dammam Pharmacy & Therapeutics Committee IABFH
Dammam, Ministry of National Guard Health Affairs.
Provided by :
Price
Course Fee
FREE
FREE
Contact Information
Organization : Virtual Medical AcademyPhone : 920008161
Email : [email protected]
Free
07 Dec 2025 To 07 Dec 2025 -
09:15 PM To 10:30 PM 
Certificate Available 
Online
- 8
Add to Calendar
12/07/2025 09:15 PM
12/07/2025 10:30 PM
Asia/ Riyadh
Transition from Clinical Trials to Real-World Evidence in Plaque Psoriasis and Psoriatic Arthritis
Transition from Clinical Trials to Real-World Evidence in Plaque Psoriasis and Psoriatic Arthritis
https://medicalacademy.org/portal/event/view/2498
